US-based Ariad Pharmaceuticals is focused on discovering, developing and commercializing precision therapies for patients with rare cancers. Ariad is working on new medicines to advance the treatment ...

About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system ...

Mallinckrodt Pharmaceuticals, Mylan Pharmaceutical AG and Medtronic Sandoz is involved in research and development efforts related to endocrine disorders, including adrenal insufficiency. The company ...

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, ...

Rigel Pharmaceuticals (RIGL) is issuing a Dear Health Care Provider – DHCP – letter related to a new safety signal for Gavreto – pralsetinib – after consultation with the FDA. Gavreto is ...

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL), a commercial stage biotechnology company focused on ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...